Advertisement

Ads Placeholder
Loading...

NeuroPace, Inc.

NPCENASDAQ
Healthcare
Medical - Devices
$14.65
$0.58(4.12%)
U.S. Market opens in 20h 27m

NeuroPace, Inc. (NPCE) Stock Overview

Explore NeuroPace, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap493.2M
P/E Ratio-22.33
EPS (TTM)$-0.66
ROE-1.06%
Fundamental Analysis

AI Price Forecasts

1 Month$11.14
3 Months$13.38
1 Year Target$16.94

NPCE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NeuroPace, Inc. (NPCE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.33 and a market capitalization of 493.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.12%
5-Day Change
8.68%
1-Month Change
5.93%
3-Month Change
-3.43%
6-Month Change
34.16%
Year-to-Date (YTD) Change
-3.43%
1-Year Change
12.61%
3-Year Change
202.07%
5-Year Change
-41.31%
All-Time (Max) Change
-41.31%

Contact Information

650 237 2700
455 North Bernardo Avenue, Mountain View, CA, 94043

Company Facts

1,840 Employees
IPO DateApr 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions